Chao-Ke Tang Selected Research

Lipoprotein Lipase (Diacylglycerol Lipase)

10/2020	Artesunate inhibits atherosclerosis by upregulating vascular smooth muscle cells-derived LPL expression via the KLF2/NRF2/TCF7L2 pathway.
1/2020	The Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript-1 Regulates CCDC80 Expression by Targeting miR-141-3p/miR-200a-3p in Vascular Smooth Muscle Cells.
10/2019	Krüppel-like factor 14 inhibits atherosclerosis via mir-27a-mediated down-regulation of lipoprotein lipase expression in vivo.
1/2019	Coiled-coil domain-containing 80 accelerates atherosclerosis development through decreasing lipoprotein lipase expression via ERK1/2 phosphorylation and TET2 expression.
12/2017	MicroRNA-182 Promotes Lipoprotein Lipase Expression and Atherogenesisby Targeting Histone Deacetylase 9 in Apolipoprotein E-Knockout Mice.
1/2016	MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
1/2015	MicroRNA-590 Inhibits Lipoprotein Lipase Expression and Prevents Atherosclerosis in apoE Knockout Mice.
12/2014	Lipoprotein lipase: from gene to atherosclerosis.
11/2014	MicroRNA-590 attenuates lipid accumulation and pro-inflammatory cytokine secretion by targeting lipoprotein lipase gene in human THP-1 macrophages.
2/2014	[Lipoprotein lipase and diabetic cardiomyopathy].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chao-Ke Tang Research Topics

Disease

67	Atherosclerosis 01/2022 - 12/2007
17	Inflammation (Inflammations) 01/2022 - 04/2011
15	Atherosclerotic Plaque (Atheroma) 01/2021 - 05/2010
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 07/2009
4	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2015
3	Pathologic Processes 01/2021 - 01/2017
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2018 - 01/2011
3	Insulin Resistance 02/2016 - 06/2012
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2021
2	Rupture 01/2021 - 01/2015
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Ventricular Remodeling 01/2021
1	COVID-19 05/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Adenocarcinoma of Lung 01/2020
1	Sepsis (Septicemia) 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Thrombosis (Thrombus) 11/2018
1	Infections 12/2016
1	Starvation 02/2016

Drug/Important Bio-Agent (IBA)

34	CholesterolIBA 01/2022 - 03/2004
25	LipidsIBA 01/2021 - 12/2007
19	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2014
10	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 10/2020 - 02/2014
10	ApolipoproteinsIBA 10/2019 - 01/2014
9	CytokinesIBA 01/2019 - 05/2010
7	oil red OIBA 01/2021 - 12/2017
6	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2021 - 03/2004
6	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2018 - 03/2004
5	Triglycerides (Triacylglycerol)IBA 01/2022 - 04/2013
5	Hematoxylin (Haematoxylon)IBA 01/2021 - 12/2017
5	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 12/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2013
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2012
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2014
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 04/2013
3	Insulin (Novolin)FDA Link 01/2022 - 04/2013
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2015
3	Biological ProductsIBA 01/2019 - 12/2014
3	oxidized low density lipoproteinIBA 01/2019 - 12/2007
3	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2019 - 06/2012
3	Lipoproteins (Lipoprotein)IBA 01/2015 - 12/2007
2	Carrier Proteins (Binding Protein)IBA 01/2022 - 05/2016
2	myocardinIBA 01/2021 - 01/2017
2	Long Noncoding RNAIBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 10/2020 - 01/2019
2	LDL CholesterolIBA 01/2019 - 09/2016
2	LipopolysaccharidesIBA 01/2019 - 01/2018
2	MicroRNAs (MicroRNA)IBA 11/2018 - 06/2012
2	HDL LipoproteinsIBA 12/2016 - 01/2012
2	AdipokinesIBA 08/2015 - 05/2013
2	ApelinIBA 01/2014 - 02/2013
2	Advanced Oxidation Protein Products (AOPP)IBA 01/2014 - 01/2011
2	Phospholipids (Phosphatides)FDA LinkGeneric 04/2013 - 03/2004
1	SterolsIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	EndocannabinoidsIBA 01/2022
1	AntigensIBA 01/2021
1	ResistinIBA 01/2021
1	Zinc Finger E-box-Binding Homeobox 1IBA 01/2021
1	CAP1-6DIBA 01/2021
1	astragalinIBA 01/2021
1	artemisinin (artemisinine)IBA 10/2020
1	ArtesunateIBA 10/2020
1	VaccinesIBA 05/2020
1	Angiopoietin-1IBA 01/2020
1	fargesinIBA 01/2020
1	CXC ChemokinesIBA 08/2019
1	LigandsIBA 08/2019
1	itaconic acidIBA 01/2019
1	HDL CholesterolIBA 01/2019
1	tanshinoneIBA 01/2019
1	CollagenIBA 01/2019
1	nobiletinIBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 11/2018
1	teleocalcinIBA 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 10/2018
1	MethyltransferasesIBA 10/2018
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2017
1	LuciferasesIBA 12/2017
1	HSP27 Heat-Shock ProteinsIBA 09/2017
1	sortilinIBA 09/2016
1	PPAR alphaIBA 02/2016
1	AdiponectinIBA 02/2016
1	fibroblast growth factor 21IBA 02/2016
1	PPAR gammaIBA 02/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Histone MethyltransferasesIBA 01/2016
1	apelin-13 peptideIBA 10/2015
1	InterferonsIBA 02/2015
1	Fibric Acids (Fibrates)IBA 01/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2014

Therapy/Procedure

2	Therapeutics 08/2019 - 01/2019